Literature DB >> 22754691

Quality of life in hemophilia complicated by inhibitors.

P Bastani1, K Pourmohamadi, M Karimi.   

Abstract

Entities:  

Keywords:  Hemophilia; Inhibitors; Iran; Quality of life

Year:  2012        PMID： 22754691      PMCID： PMC3385807     

Source DB:  PubMed          Journal:  Iran Red Crescent Med J        ISSN： 2074-1804            Impact factor:   0.611


× No keyword cloud information.
  9 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  J E Ware; B Gandek; M Kosinski; N K Aaronson; G Apolone; J Brazier; M Bullinger; S Kaasa; A Leplège; L Prieto; M Sullivan; K Thunedborg
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

3.  Health status and health-related quality of life associated with hemophilia.

Authors:  Ronald D Barr; Mahassen Saleh; William Furlong; John Horsman; Julia Sek; Mohan Pai; Irwin Walker
Journal:  Am J Hematol       Date:  2002-11       Impact factor: 10.047

4.  Efficacy and safety of vapor-heated anti-inhibitor coagulant complex in hemophilia patients. FEIBA Study Group.

Authors:  M Hilgartner; L Aledort; A Andes; J Gill
Journal:  Transfusion       Date:  1990-09       Impact factor: 3.157

5.  Hemophilia. Treatment of patients with inhibitors: cost issues.

Authors:  J Goudemand
Journal:  Haemophilia       Date:  1999-11       Impact factor: 4.287

6.  Epidemiology of inhibitors in haemophilia A.

Authors:  W Kreuz; C Escuriola-Ettingshausen; I Martinez-Saguer; T Güngör; B Kornhuber
Journal:  Vox Sang       Date:  1996       Impact factor: 2.144

Review 7.  Hemophilia. Strategies for the treatment of inhibitor patients.

Authors:  J Ingerslev
Journal:  Haematologica       Date:  2000-10       Impact factor: 9.941

Review 8.  State of care for hemophilia in pediatric patients.

Authors:  Elena Santagostino; Alessandro Gringeri; Pier M Mannucci
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

9.  Immune tolerance in hemophilia-principal results from the International Registry. Report of the factor VIII and IX Subcommittee.

Authors:  G Mariani; A Ghirardini; R Bellocco
Journal:  Thromb Haemost       Date:  1994-07       Impact factor: 5.249
  9 in total
  1 in total

1.  Associations of quality of life, pain, and self-reported arthritis with age, employment, bleed rate, and utilization of hemophilia treatment center and health care provider services: results in adults with hemophilia in the HERO study.

Authors:  Angela L Forsyth; Michelle Witkop; Angela Lambing; Cesar Garrido; Spencer Dunn; David L Cooper; Diane J Nugent
Journal:  Patient Prefer Adherence       Date:  2015-10-29       Impact factor: 2.711
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.